Bioadhesive controlled release systems of ornidazole for vaginal delivery

被引:32
作者
Baloglu, Esra [1 ]
Oezyazici, Mine
Hizarcioglu, Sinem Yaprak
Senygit, Taner
Oezyurt, Dogan
Pekcetin, Cetin
机构
[1] Ege Univ, Fac Pharm, Dept Pharmaceut Technol, Izmir, Turkey
[2] Dokuz Eylul Univ, Fac Med, Dept Histol Embriyol, Izmir, Turkey
关键词
ornidazole; vaginal tablet; bioadhesion; swelling-controlled; carbopol; 934;
D O I
10.1080/10837450600939784
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
Our objective was to develop a bioadhesive vaginal tablet formulation of ornidazole by using different polymer mixtures, to evaluate the bioadhesive tablet properties, and to investigate the irritation potential of the formulations to the rat vaginal tissue. Vaginal tablets of ornidazole were directly compressed with bioadhesive and swellable polymer mixtures as release-controlled agents. Carbopol 934 (Cp), pectin (Pc), hydroxypropylmethylcellulose (HPMC), sodium carboxymethylcellulose (Na CMC), and guar gum (GG) were used in different ratios. Bioadhesive properties, swelling capacity, release studies, and histological studies of the formulations were carried out. The bioadhesive strength between bovine vagina and surface of the tablets was determined by tensile experiments, and it was found to be dependent on Cp content. The release mechanism was described and found to be non-Fickian for all formulations. Dissolution data were evaluated statistically. No histological damage was found except one formulation containing high amount of guar gum.
引用
收藏
页码:477 / 484
页数:8
相关论文
共 40 条
[1]
Evaluation of the mucosal irritation potency of co-spray dried Amioca®/poly (acrylic acid) and Amioca®/Carbopol® 974P mixtures [J].
Adriaens, E ;
Ameye, D ;
Dhondt, MMM ;
Foreman, P ;
Remon, JP .
JOURNAL OF CONTROLLED RELEASE, 2003, 88 (03) :393-399
[2]
Baloglu E., 2003, Farmaco (Lausanne), V58, P391, DOI 10.1016/S0014-827X(03)00044-2
[3]
DEVELOPMENT AND TESTING OF BIOADHESIVE, FLUORIDE-CONTAINING SLOW-RELEASE TABLETS FOR ORAL USE [J].
BOTTENBERG, P ;
CLEYMAET, R ;
DEMUYNCK, C ;
REMON, JP ;
COOMANS, D ;
MICHOTTE, Y ;
SLOP, D .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1991, 43 (07) :457-464
[4]
BOTTENBERG P, 1989, STP PHARM, V5, P863
[5]
Spreading and retention of vaginal formulations in post-menopausal women as assessed by gamma scintigraphy [J].
Brown, J ;
Hooper, G ;
Kenyon, CJ ;
Haines, S ;
Burt, J ;
Humphries, JM ;
Newman, SP ;
Davis, SS ;
Sparrow, RA ;
Wilding, IR .
PHARMACEUTICAL RESEARCH, 1997, 14 (08) :1073-1078
[6]
CHING HS, 1985, J PHARM SCI, V74, P399
[7]
Development of in situ gelling and mucoadhesive acetaminophen liquid suppository [J].
Choi, HG ;
Jung, JH ;
Ryu, JM ;
Yoon, SJ ;
Oh, YK ;
Kim, CK .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1998, 165 (01) :33-44
[8]
Colombo, 2000, Pharm Sci Technol Today, V3, P198, DOI 10.1016/S1461-5347(00)00269-8
[9]
CRUZ O, 2001, CONTRACEPTION, V64, P113
[10]
Association between bacterial vaginosis and expression of human immunodeficiency virus type 1 RNA in the female genital tract [J].
Cu-Uvin, S ;
Hogan, JW ;
Caliendo, AM ;
Harwell, J ;
Mayer, KH ;
Carpenter, CCJ .
CLINICAL INFECTIOUS DISEASES, 2001, 33 (06) :894-896